Indicators

Markets:

News

Latest News about RGNX

Recent news which mentions RGNX

< Previous 1 2 3 4 5 Next >

What 4 Analyst Ratings Have To Say About Regenxbio

September 09, 2022

4 Analysts Have This to Say About Regenxbio

August 10, 2022

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

August 03, 2022

Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial

August 03, 2022

Regenxbio's Earnings Outlook

August 02, 2022

Expert Ratings for Regenxbio

June 23, 2022

Benzinga's Top Ratings Upgrades, Downgrades For June 23, 2022

June 23, 2022

5 Small-Cap S&P Stocks To Buy With The Most Upside

May 26, 2022

Regenxbio's Return On Capital Employed Overview

May 24, 2022

Expert Ratings for Regenxbio

May 24, 2022

The Daily Biotech Pulse: Pfizer-BioNTech's COVID-19 Booster For Kids 5-11 Coming Soon, Ultragenyx In-Licenses Gene Therapy For Genetic Disorder, Ampio's AP-013 Trial Under Independent Investigation

May 17, 2022

5 Value Stocks In The Healthcare Sector

May 16, 2022

The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More

May 16, 2022

12 Health Care Stocks Moving In Friday's After-Market Session

May 06, 2022

83 Biggest Movers From Yesterday

May 06, 2022

57 Stocks Moving In Thursday's Mid-Day Session

May 05, 2022

Expert Ratings for Regenxbio

May 05, 2022

The Daily Biotech Pulse: Kezar Life's Lead Asset Fails, Brickell Biotech Offloads Late-Stage Asset, Connect Biopharma Ulcerative Colitis Trial Disappoints

May 04, 2022

3 Small-Cap Medical Stocks With Big Momentum

April 27, 2022

7 Top-Rated Biotech Stocks to Buy for Q2

April 21, 2022

Regenxbio's Return On Capital Employed Overview

March 07, 2022

Expert Ratings For Regenxbio

March 02, 2022

The Daily Biotech Pulse: Karyopharm Flags Delay In Selinexor Label Expansion, Finch, Celyad Hit With Clinical Holds, Adagene Strikes R&D Collaboration With Sanofi

March 02, 2022

Regenxbio: Q4 Earnings Insights

March 01, 2022

The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution

March 01, 2022

Earnings Scheduled For March 1, 2022

March 01, 2022

Earnings Preview: Regenxbio

February 28, 2022

The Week Ahead In Biotech (Feb. 27-March 5): Earnings, Multiple Regulatory Decisions Take The Spotlight

February 27, 2022

RegenXBio Posts Updated Data From Hunter Syndrome Gene Therapy Trial

February 09, 2022

The Daily Biotech Pulse: Bristol-Myers Squibb Announces $5B Accelerated Buyback, Qiagen Reaps COVID Testing Windfall, WORLDSymposium Presentations Kick In

February 09, 2022

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.